Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles. | Front Immunol | 2022 | 35874704 | PubTator, text mining | PubMed |
| Eukaryotic Translation Initiation Factor 5A Independently Predicts Poor Prognosis of Cholangiocarcinoma Patients and Regulates the Ferroptosis and Mitochondrial Apoptosis. | J Oncol | 2022 | 35874632 | PubTator, text mining | PubMed |
| Coactosin-Like Protein in Breast Carcinoma: Friend or Foe? | J Inflamm Res | 2022 | 35873386 | PubTator, text mining | PubMed |
| Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype. | Front Immunol | 2022 | 35860266 | PubTator, text mining | PubMed |
| ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. | Front Immunol | 2022 | 35860243 | PubTator, text mining | PubMed |
| Therapeutic targeting of regulatory T cells in cancer. | Trends Cancer | 2022 | 35853825 | PubTator, text mining | PubMed |
| DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis. | Int J Gen Med | 2022 | 35846794 | PubTator, text mining | PubMed |
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats. | Drug Alcohol Depend | 2022 | 35843139 | PubTator, text mining | PubMed |
| Identification and Validation of Prognostic Related Hallmark ATP-Binding Cassette Transporters Associated With Immune Cell Infiltration Patterns in Thyroid Carcinoma. | Front Oncol | 2022 | 35837087 | PubTator, text mining | PubMed |
| The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. | Front Immunol | 2022 | 35833147 | PubTator, text mining | PubMed |
| Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC). | Cell Death Dis | 2022 | 35831283 | PubTator, text mining | PubMed |
| A CD4+ T cell reference map delineates subtype-specific adaptation during acute and chronic viral infections. | Elife | 2022 | 35829695 | PubTator, text mining | PubMed |
| Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103. | Life Sci | 2022 | 35817166 | PubTator, text mining | PubMed |
| CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer. | Oncol Lett | 2022 | 35814828 | PubTator, text mining | PubMed |
| Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35812416 | PubTator, text mining | PubMed |
| Barriers and Opportunities for CAR T-Cell Targeting of Solid Tumors. | Immunol Invest | 2022 | 35797428 | PubTator, text mining | PubMed |
| eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma. | J Transl Med | 2022 | 35794622 | PubTator, text mining | PubMed |
| Avidity in antibody effector functions and biotherapeutic drug design. | Nat Rev Drug Discov | 2022 | 35790857 | PubTator, text mining | PubMed |
| Identification of COL1A1 associated with immune infiltration in brain lower grade glioma. | PLoS One | 2022 | 35789341 | PubTator, text mining | PubMed |
| Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values. | BMC Pulm Med | 2022 | 35768814 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=31